Products Liability Updates – May 21, 2012

by Patrick Malone & Associates P.C. | DC Injury... on 5/18/2012

Nearly 50 years ago, Dr. Harry Shirkey coined the phrase "therapeutic orphan" to describe children who took prescription medicine. Because drug studies among a pediatric population were complicated and offered little...more

by Michael Durr on 5/17/2012

A challenging fire loss in Tennessee....more

by Dechert LLP on 5/16/2012

Yesterday, we blogged about a case where plaintiff failed to do even the most basic investigation to identify the product at issue before filing suit. She was hoping her case would survive with some vague pleadings in the...more

by Cadwalader, Wickersham & Taft LLP on 5/15/2012

Originally published in New York Law Journal - Volume 247—NO. 85, Thursday, May 3, 2012. On April 10, 2012, the U.S. Court of Appeals for the Second Circuit in In re Quigley issued an opinion adopting a narrow...more

by Dechert LLP on 5/14/2012

As another work-week starts, we thought we’d talk about beginnings – in particular, beginnings to adversarial contests. They almost always begin after the adversaries and the stakes have been identified. In the NHL, for...more

by Patrick Malone & Associates P.C. | DC Injury... on 5/14/2012

Here’s another arrow for the quiver of people exasperated with government. As part of its health-care reform, the Obama Administration proposed that drug companies be made to disclose payments they make to doctors for...more

by Hissey Kientz LLP on 5/10/2012

Asbestos is a naturally-occurring mineral that is found in six different varieties, each of which can be used for different industrial or manufacturing applications. Workers who are exposed to asbestos may face an increased...more

by Dechert LLP on 5/9/2012

We can't say much about it because of Dechert's involvement in the Reglan/metoclopramide litigation, but Judge Higbee has ruled on on generic preemption under Mensing. There are two opinions. The first, In re Reglan...more